title: Developmental neuroplasticity and the origin of neurodegenerative diseases.
abstract: Neurodegenerative diseases like Alzheimer's and Parkinson's Disease, marked by characteristic protein aggregations, are more and more accepted to be synaptic disorders and to arise from a combination of genetic and environmental factors. In this review we propose our concept that neuroplasticity might constitute a link between early life challenges and neurodegeneration.
  
  
  
  After introducing the general principles of neuroplasticity, we show how adverse environmental stimuli during development impact adult neuroplasticity and might lead to neurodegenerative processes.
  
  
  
  There are significant overlaps between neurodevelopmental and neurodegenerative processes. Proteins that represent hallmarks of neurodegeneration are involved in plastic processes under physiological conditions. Brain regions - particularly the hippocampus - that retain life-long plastic capacities are the key targets of neurodegeneration. Neuroplasticity is highest in young age making the brain more susceptible to external influences than later in life. Impacts during critical periods have life-long consequences on neuroplasticity and structural self-organization and are known to be common risk factors for neurodegenerative diseases.
  
  
  
  Several lines of evidence support a link between developmental neuroplasticity and neurodegenerative processes later in life. A deeper insight into these processes is necessary to design strategies to mitigate or even prevent neurodegenerative pathologies.
authors.affiliation: a Department of Biology , University of Bielefeld , Bielefeld , Germany.
authors.forename: Andrea T U
authors.initials: AT
authors.lastname: Schaefers
authors.affiliation: a Department of Biology , University of Bielefeld , Bielefeld , Germany.
authors.forename: Gertraud
authors.initials: G
authors.lastname: Teuchert-Noodt
mesh_terms: D000375:Aging / Q000502:physiology*; D000544:Alzheimer Disease / Q000503:physiopathology*; D016229:Amyloid beta-Peptides / Q000378:metabolism; D006624:Hippocampus / Q000254:growth & development / Q000503:physiopathology*; D006801:Humans; D009473:Neuronal Plasticity / Q000502:physiology*; D010300:Parkinson Disease / Q000503:physiopathology*
chemical_list: D016229:Amyloid beta-Peptides
keywords: Alzheimer's disease; Neurodegenerative diseases; Parkinson's disease; brain development; neuroplasticity